kit for the preparation of 99mTc – HYNICTOC
Gastro-entero-pancreatic neuroendocrine tumors (GEP-NET);
– pituitary adenomas;
– tumours originating in a sympathetic system; pheochromocytoma, paraganglioma,
neuroblastoma, ganglioneurinoma and so on;
– medullary carcinoma of thyroid;
– the preparation may be potentially useful in the case of other tumours expressing
somatostatin receptors of various intensity. Other tumours which may express
overexpression of somatostatin receptors: breast cancer, malignant melanoma,
lymphomas, prostate cancer, sarcoma, clear cell carcinoma of the kidney,
differentiated carcinoma of thyroid, astrocytoma WHO I-IV (including glioblastoma
multiforme G-M), meningioma, ovarian carcinoma.
– pituitary adenomas;
– tumours originating in a sympathetic system; pheochromocytoma, paraganglioma,
neuroblastoma, ganglioneurinoma and so on;
– medullary carcinoma of thyroid;
– the preparation may be potentially useful in the case of other tumours expressing
somatostatin receptors of various intensity. Other tumours which may express
overexpression of somatostatin receptors: breast cancer, malignant melanoma,
lymphomas, prostate cancer, sarcoma, clear cell carcinoma of the kidney,
differentiated carcinoma of thyroid, astrocytoma WHO I-IV (including glioblastoma
multiforme G-M), meningioma, ovarian carcinoma.
2 vials
60 mCi in 1ml volume of 99mTc
20 mCi – 25 mCi depending on the patient’s weight
2 – 8 0C
Two working days before the delivery date
At least 12 months after production
77774/5-11-2012
The two vials are used for the same labeling procedure.
